PRESS RELEASE published on 10/31/2023 at 15:16, 2 years 1 month ago PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED
PRESS RELEASE published on 10/26/2023 at 12:50, 2 years 1 month ago EQS-Adhoc: PAION AG: Filing an application for the opening of insolvency proceedings
PRESS RELEASE published on 10/20/2023 at 07:30, 2 years 1 month ago PAION AG to issue approximately 4.8 million shares at EUR 1.90 per share in capital increase with subscription rights
PRESS RELEASE published on 10/19/2023 at 20:56, 2 years 1 month ago EQS-Adhoc: PAION AG to issue approximately 4.8 million shares in capital increase with subscription rights
PRESS RELEASE published on 10/13/2023 at 13:06, 2 years 1 month ago PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million
PRESS RELEASE published on 10/13/2023 at 12:57, 2 years 1 month ago EQS-Adhoc: PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million
PRESS RELEASE published on 09/28/2023 at 14:00, 2 years 2 months ago PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE MUNDIPHARMA IN JAPAN
PRESS RELEASE published on 09/18/2023 at 15:26, 2 years 2 months ago Original-Research: PAION AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 08/31/2023 at 14:00, 2 years 3 months ago PAION receives UK MHRA approval of Byfavo® (remimazolam) for the induction and maintenance of general anesthesia in adults
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 3 months ago PAION AG reports financial results for the First Half-Year 2023
Published on 12/05/2025 at 02:35, 4 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 11 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 51 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 16 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 27 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 31 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 27 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
